Development of GMP protocols began at MCT. Our program was working in collaboration with a start-up company called NuQure, which later became CIPAC, then Crestovo, and ultimately Finch Therapeutics.
University of Minnesota
http://twin-cities.umn.edu/
612-625-5000
http://twin-cities.umn.edu/
612-625-5000
